BRCA1 promoter methylation rates of 41.67%, 46.67%, and 19.05% were detected, respectively, in malignant breast tumors (MBTs), normal adjacent tissues (NATs), and benign breast lesions (BBLs). Here, BRCA1 is linked to breast cancer.